ClearPoint Neuro, Inc. (CLPT)
NASDAQ: CLPT · Real-Time Price · USD
15.19
-0.77 (-4.82%)
Aug 20, 2026, 4:00 PM EDT - Market closed

ClearPoint Neuro Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
42.2836.9731.3923.9620.5516.3
Revenue Growth
25.86%17.78%31.04%16.56%26.09%27.05%
Gross Profit
26.4722.6919.1213.6113.5311.12
Operating Income
-29.24-22.36-19.73-22.45-16.33-13.37
Net Income
-34.57-25.54-18.91-22.09-16.44-14.41
Earnings Per Share
-1.18-0.90-0.70-0.90-0.68-0.69
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
29.3645.9220.123.1437.4954.11
Total Debt
63.9558.233.5713.9411.9912.28
Net Cash (Debt)
-34.58-12.3116.549.225.541.83
Net Cash Growth
--79.76%-63.93%-39.02%-
Net Cash Per Share
-1.18-0.430.610.371.052.02

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-30.18-23.93-8.95-13.72-16.17-12.7
Capital Expenditures
-1.11-0.52-0.28-0.72-0.25-0.17
Free Cash Flow
-31.29-24.45-9.23-14.44-16.42-12.87
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
62.61%61.38%60.92%56.83%65.84%68.24%
Operating Margin
-69.17%-60.49%-62.87%-93.70%-79.47%-82.05%
Pretax Margin
-81.80%-68.93%-60.22%-92.21%-79.97%-88.41%
Profit Margin
-81.76%-69.08%-60.26%-92.21%-79.97%-88.41%
FCF Margin
-74.01%-66.13%-29.39%-60.27%-79.90%-78.93%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
10.9611.0113.526.9810.1216.27